Trials in isolated systolic hypertension: an update.

Details

Serval ID
serval:BIB_29190
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Trials in isolated systolic hypertension: an update.
Journal
Current Hypertension Reports
Author(s)
Waeber B.
ISSN
1522-6417
Publication state
Published
Issued date
2003
Peer-reviewed
Oui
Volume
5
Number
4
Pages
329-336
Language
english
Notes
Publication types: Journal Article ; Review
Abstract
Isolated systolic hypertension (ISH) has proved to be a powerful predisposing factor for cardiovascular diseases in the elderly. Recent placebo-controlled interventional trials such as the Systolic Hypertension in the Elderly Program (SHEP), the Systolic Hypertension in Europe (Syst-Eur), and the Systolic Hypertension in China (Syst-China) showed that the lowering of systolic blood pressure using a diuretic- or a calcium antagonist-based treatment is associated with a decrease in cardiovascular events. Antihypertensive therapy was found especially effective in preventing stroke in the elderly with ISH. A slowing in the progression of dementia was observed in patients randomized to a calcium antagonist-based treatment. Patients at high cardiovascular risk such as those with diabetes benefited the most from treatment. In another trial performed in patients with left ventricular hypertrophy (Losartan Intervention For Endpoint Reduction ), a subset of patients had ISH. In those patients, an angiotensin II antagonist-based treatment was superior to a b-blocker-based treatment in preventing cardiovascular complications. The experience accumulated in patients with ISH showed that combination therapy is often required to control blood pressure. Overall, the evidence available today indicates that pharmacologic treatment of ISH markedly improves the outcome of elderly patients.
Keywords
Aged, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Dementia, Depression, Diabetic Angiopathies, Humans, Hypertension, Kidney, Quality of Life, Randomized Controlled Trials as Topic, Stroke, Systole
Pubmed
Web of science
Create date
19/11/2007 12:26
Last modification date
20/08/2019 13:08
Usage data